660 related articles for article (PubMed ID: 31501049)
1. The Utility of Whole Body
Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
[TBL] [Abstract][Full Text] [Related]
2. How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body
Juneau D; Nery P; Russo J; de Kemp RA; Leung E; Beanlands RSB; Birnie DH
Int J Cardiol; 2018 Feb; 253():189-193. PubMed ID: 29306462
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Lu Y; Grant C; Xie K; Sweiss NJ
Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
[TBL] [Abstract][Full Text] [Related]
4. [
Borges-Rosa J; Oliveira-Santos M; Silva R; Gomes A; de Almeida J; Costa G; Gonçalves L; Ferreira MJ
Int J Cardiol; 2022 Jan; 347():38-43. PubMed ID: 34736982
[TBL] [Abstract][Full Text] [Related]
5.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
Okada T; Kawaguchi N; Miyagawa M; Matsuoka M; Tashiro R; Tanabe Y; Kido T; Miyoshi T; Higashi H; Inoue T; Okayama H; Yamaguchi O; Kido T
J Nucl Cardiol; 2023 Feb; 30(1):280-289. PubMed ID: 35804283
[TBL] [Abstract][Full Text] [Related]
7. Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.
Tanabe S; Nakano Y; Ando H; Fujimoto M; Onishi T; Ohashi H; Kuno S; Naito K; Waseda K; Takahashi H; Suzuki Y; Fukuta M; Amano T
Sci Rep; 2024 Apr; 14(1):7825. PubMed ID: 38570621
[TBL] [Abstract][Full Text] [Related]
8. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
9. Inter- and Intraobserver Agreement of
Ohira H; Ardle BM; deKemp RA; Nery P; Juneau D; Renaud JM; Klein R; Clarkin O; MacDonald K; Leung E; Nair G; Beanlands R; Birnie D
J Nucl Med; 2017 Aug; 58(8):1324-1329. PubMed ID: 28254873
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
[TBL] [Abstract][Full Text] [Related]
11. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.
Schildt JV; Loimaala AJ; Hippeläinen ET; Ahonen AA
Eur Heart J Cardiovasc Imaging; 2018 Mar; 19(3):293-298. PubMed ID: 28950301
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of isolated cardiac sarcoidosis based on new guidelines.
Kawai H; Sarai M; Kato Y; Naruse H; Watanabe A; Matsuyama T; Takahashi H; Motoyama S; Ishii J; Morimoto SI; Toyama H; Ozaki Y
ESC Heart Fail; 2020 Oct; 7(5):2662-2671. PubMed ID: 32578957
[TBL] [Abstract][Full Text] [Related]
14. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
15. Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography.
Maeda D; Kanzaki Y; Fujita S; Inuyama M; Takashima S; Miyamura M; Terasaki F; Hoshiga M
ESC Heart Fail; 2019 Aug; 6(4):889-893. PubMed ID: 31264810
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
17. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
19. ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.
Ohira H; Tsujino I; Yoshinaga K
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1773-83. PubMed ID: 21559980
[TBL] [Abstract][Full Text] [Related]
20. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
